Susceptibilities of 228 penicillin- and erythromycin-susceptible and - resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1033-1036

  Ednie, L M ^a   Spangler, S K ^a   Jacobs, M R ^b   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; HMR 3004; IMIPENEM; MACROLIDE; PENICILLIN G; PRISTINAMYCIN; ROKITAMYCIN; SPARFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030956596     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1033     Document Type: Article

References (21)

1. Agouridas, C., Y. Benedetti, A. Denis, C. Fromentin, S. Gouin D'Ambrieres, O. Le Martret, and J. F. Chantot. 1994. Ketolides, a new distinct semi-synthetic class of macrolides, abstr. F-164, p. 227. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1994. Ketolides, a new distinct semi-synthetic class of macrolides: in-vitro and in-vivo antibacterial activities, abstr. F-168, p. 227. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Agouridas C., P. Collette, P. Mauvais, and J. F. Chantot. 1994. Ketolides, a new distinct semi-synthetic class of macrolides: studies on the mechanism of action, abstr. F-166, p. 227. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
5. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
6. Block, S., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 14:751-759.
7. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
8. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
9. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
10. Geslin, P., A. Fremaux, G. Sissia, C. Spicq, and A. Aberrane. 1994. Epidemiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France. Réseau national de surveillance (1984-1993). Med. Mal. Infect. 24:948-961.
11. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
12. Liñares, J., T. Alonso, J. Ayats, F. Alcaide, F. Tubau, J. Hernandez, and R. Martin. 1991. In vitro activity of 7 macrolide antibiotics and 9 other antimicrobial agents against penicillin-resistant pneumococci, abstr. 191, p. 130. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Liñares, J., T. Alonso, J. L. Pérez, J. Ayats, M. A. Domínguez, R. Pallarés, and R. Martín. 1992. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J. Antimicrob. Chemother. 30: 279-288.
14. Mason, E. O., Jr., S. L. Kaplan, L. B. Lamberth, and J. Tillman. 1992. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob. Agents Chemother. 36:1703-1707.
15. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
16. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. NCCLS publication no. M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
18. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
19. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob. Agents Chemother. 38:2902-2904.
20. Spangler, S. K., M. R. Jacobs, G. A. Pankuch, and P. C. Appelbaum. 1993. Susceptibility of 170 penicillin-susceptible and -resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J. Antimicrob. Chemother. 31:273-280.
21. Tweardy, D. J., M. R. Jacobs, and W. T. Speck. 1983. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials; implications for treatment of meningitis. J. Antimicrob. Chemother. 12:133-139.